Superficial Radiation Therapy (SRT) treatment that requires minimal to no cutting, no scarring, and no down time!. SRT provides a Non-Surgical Alternative for Non-Melanoma Skin Cancer & an Effective Solution for Keloids. Superficial Radiation Therapy is giving new hope to those affected by keloids.
When Superficial Radiation Therapy (SRT) is used after the removal of keloids, the cure rate is an astonishing 94%! With a high-frequency ultra-sound guidance system, the SRT-100 Vision allows physicians to view treatment areas while they are being treated. Are you a healthcare professional? Would you like an easy way to offer in-office aesthetic lasers procedures without the hassle that comes with equipment ownership in-office?
When Superficial Radiation Therapy (SRT) is used after the removal of keloids, the cure rate is an astonishing 94%! With a high-frequency ultra-sound guidance system, the SRT-100 Vision allows physicians to view treatment areas while they are being treated. Are you a healthcare professional? Would you like an easy way to offer in-office aesthetic lasers procedures without the hassle that comes with equipment ownership in-office?
Services
Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for both oncological and non-oncological conditions.
The recently introduced Sculptura robotic radiation oncology system provides targeted intraoperative triple-modulated radiotherapy (IORT) and Brachytherapy utilizing our proprietary, state-of-the-art 3D Beam Sculpting to treat patients undergoing cancer treatment during surgery, or at the tumor site, fast and efficiently.
The recently introduced Sculptura robotic radiation oncology system provides targeted intraoperative triple-modulated radiotherapy (IORT) and Brachytherapy utilizing our proprietary, state-of-the-art 3D Beam Sculpting to treat patients undergoing cancer treatment during surgery, or at the tumor site, fast and efficiently.
Dr. William Roth presents three cases of non-melanoma skin cancer being treated by Superficial Radiation Therapy (SRT). Look at these. Hear from the patients themselves! These individuals had their non-melanoma skin cancer treated with SRT and have achieved amazing results. We had the pleasure of inviting patient advocate Tony Perkins to the Sensus Headquarters to tell his story of how.
What is the cure rate of basal and squamous cell skin cancer when treated with the SRT-100?. The SRT-100 is comparable to surgery and is 98.7 percent plus effective in curing basal and squamous cell skin cancer. The SRT-100 is very effective in treating keloids and boasts a cure rate of 94 percent plus.
As a physician, it is up to you to make sure your patients have access to and are making the best choices possible when it comes to treating their non-melanoma skin cancer and keloids. To do so, you must be able to present to them a variety of options for treatment and help them choose the best option for their bodies.
Sensus Healthcare, Inc. is a rapidly growing international medical device manufacturer that has been designing and distributing high quality medical devices since 2010. Sensus Healthcare manufactures a portable Superficial Radiation Therapy machine called the SRT-100 that is used primarily for the non-surgical removal of non-melanoma skin cancer and post-excision keloid treatment for healthcare providers around the globe.
Reviews
Be the first to review Sensus Healthcare.
Write a Review
